{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T11:22:04Z","timestamp":1785842524091,"version":"3.56.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.ygyno.2012.07.112","type":"journal-article","created":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T12:47:48Z","timestamp":1343479668000},"page":"321-325","source":"Crossref","is-referenced-by-count":54,"title":["Five-year outcomes of adjuvant carboplatin\/paclitaxel chemotherapy and intravaginal radiation for stage I\u2013II papillary serous endometrial cancer"],"prefix":"10.1016","volume":"127","author":[{"given":"Ana P.","family":"Kiess","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shari","family":"Damast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicky","family":"Makker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa A.","family":"Kollmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ginger J.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Aghajanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard R.","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaled M.","family":"Alektiar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2012.07.112_bb0005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2009.06.011","article-title":"Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review","volume":"115","author":"Boruta","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.07.112_bb0010","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/sj.bjc.6603012","article-title":"Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers","volume":"94","author":"Hamilton","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ygyno.2012.07.112_bb0015","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.ygyno.2003.08.027","article-title":"Uterine papillary serous carcinoma: comparisons of outcomes in surgical stage I patients with and without adjuvant therapy","volume":"91","author":"Huh","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.07.112_bb0020","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/cncr.24247","article-title":"Platinum\/taxane-based chemotherapy with or without radiation therapy favorably impacts survival outcomes in stage I uterine papillary serous carcinoma","volume":"115","author":"Fader","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2012.07.112_bb0025","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ygyno.2008.11.016","article-title":"Stage II uterine papillary serous carcinoma: carboplatin\/paclitaxel chemotherapy improves recurrence and survival outcomes","volume":"112","author":"Fader","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.07.112_bb0030","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2005.06.012","article-title":"Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy","volume":"98","author":"Kelly","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.07.112_bb0035","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ygyno.2007.10.037","article-title":"Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN)","volume":"108","author":"Goldberg","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.07.112_bb0040","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ygyno.2007.01.041","article-title":"Outcomes in surgical stage I uterine papillary serous carcinoma","volume":"105","author":"Havrilesky","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.07.112_bb0045","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ygyno.2005.07.104","article-title":"The efficacy of adjuvant platinum-based chemotherapy in stage I uterine papillary serous carcinoma (UPSC)","volume":"99","author":"Dietrich","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.07.112_bb0050","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ygyno.2011.09.005","article-title":"The importance of chemotherapy and radiation in uterine papillary serous carcinoma","volume":"123","author":"Viswanathan","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.07.112_bb0055","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ygyno.2008.10.006","article-title":"Concurrent carboplatin\/paclitaxel and intravaginal radiation in surgical stage I\u2013II serous endometrial cancer","volume":"112","author":"Alektiar","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.07.112_bb0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0360-3016(97)00581-6","article-title":"Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy","volume":"40","author":"Turner","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.07.112_bb0065","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0360-3016(90)90094-Z","article-title":"Postoperative vaginal irradiation with high dose rate afterloading technique in endometrial carcinoma stage I","volume":"18","author":"Sorbe","year":"1990","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ygyno.2012.07.112_bb0070","series-title":"Uterine neoplasms, version 3.2012","author":"NCCN Clinical Practice Guidelines in Oncology","year":"2012"},{"key":"10.1016\/j.ygyno.2012.07.112_bb0075","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ygyno.2009.07.030","article-title":"An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)","volume":"115","author":"Fader","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.07.112_bb0080","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s004320050336","article-title":"Serum CA-125 as a marker of disease activity in uterine papillary serous carcinoma","volume":"125","author":"Abramovich","year":"1999","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ygyno.2012.07.112_bb0085","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ygyno.2008.05.027","article-title":"Utility of pre-operative serum CA-125 in the management of uterine papillary serous carcinoma","volume":"110","author":"Olawaiye","year":"2008","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.07.112_bb0090","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1002\/(SICI)1097-0142(19980501)82:9<1720::AID-CNCR19>3.0.CO;2-6","article-title":"CA 125 may not reflect disease status in patients with uterine serous carcinoma","volume":"82","author":"Price","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.ygyno.2012.07.112_bb0095","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ygyno.2004.05.009","article-title":"High-dose rate brachytherapy for stage I\/II papillary serous or clear cell endometrial cancer","volume":"94","author":"DuBeshter","year":"2004","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.07.112_bb0100","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ygyno.2005.01.001","article-title":"Adjuvant sequential chemotherapy and radiotherapy in uterine papillary serous carcinoma","volume":"97","author":"Low","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.07.112_bb0105","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"Nout","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.ygyno.2012.07.112_bb0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ygyno.2011.10.007","article-title":"Phase II trial of adjuvant pelvic radiation \u201csandwiched\u201d between combination paclitaxel and carboplatin in women with uterine papillary serous carcinoma","volume":"124","author":"Einstein","year":"2012","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812006385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812006385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T17:08:44Z","timestamp":1562000924000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825812006385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":22,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0090825812006385"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2012.07.112","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}